a 2018

The Role of MicroRNAs Expression Model in Head and Neck Squamous Cell Carcinoma.

SLÁVIK, Marek, Parwez AHMAD, Jiří ŠÁNA, Tetiana SHATOKHINA, Tomáš KAZDA et. al.

Basic information

Original name

The Role of MicroRNAs Expression Model in Head and Neck Squamous Cell Carcinoma.

Authors

SLÁVIK, Marek (703 Slovakia, belonging to the institution), Parwez AHMAD (356 India, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Tetiana SHATOKHINA (804 Ukraine, belonging to the institution), Tomáš KAZDA (203 Czech Republic, belonging to the institution), Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution), Pavel ŠLAMPA (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution)

Edition

37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 2018

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30204 Oncology

Country of publisher

Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14740/18:00106547

Organization unit

Central European Institute of Technology

UT WoS

000438676103047

Keywords in English

MicroRNAs Expression; Neck Squamous Cell Carcinoma

Tags

Tags

International impact, Reviewed
Změněno: 26/3/2019 15:55, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

The aim of this study was to discover a set of MicroRNAs (Mirnas) which will predict the radiation therapy response in head and neck squamous cell cancer (HNSCC) patients and be able to predict the locoregional control ( LRC) and classify these patients according to the time to local progression.

Links

LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV15-31627A, research and development project
Name: Možnosti molekulárně řízené radikální radioterapie nebo radiochemoterapie dle profilu mikroRNA u pacientů se spinocelulárními karcinomy hlavy a krku.